Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches

Demyelination in multiple sclerosis (MS) cells is the site of several energy metabolic abnormalities driven by dysregulation between the opposed interplay of peroxisome proliferator-activated receptor γ (PPARγ) and WNT/β-catenin pathways. We focus our review on the opposing interactions observed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallée, Alexandre, Lecarpentier, Yves, Guillevin, Rémy, Vallée, Jean-Noël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979570/
https://www.ncbi.nlm.nih.gov/pubmed/29659554
http://dx.doi.org/10.3390/ijms19041212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979570/
https://www.ncbi.nlm.nih.gov/pubmed/29659554
http://dx.doi.org/10.3390/ijms19041212

Ejemplares similares